Clinical trials
Phase 1/2 Esophageal Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Terminated | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Research UK | 5 |
| Seagen Inc. | 2 |
| Amgen | 1 |
| CytomX Therapeutics | 1 |
| Hoffmann-La Roche | 1 |
| Kymab Limited | 1 |
| Ludwig Institute for Cancer Research | 1 |
| Merus B.V. | 1 |
| NuCana plc | 1 |
| Oxford University Hospitals NHS Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 16 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Stomach Neoplasms | 8 |
| Squamous Cell Carcinoma of Head and Neck | 6 |
| Uterine Cervical Neoplasms | 6 |
| Neoplasms | 5 |
| Endometrial Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Triple Negative Breast Neoplasms | 4 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.